The effort began in June 2022, after the WTO reached a five-year arrangement to waive patent rights for Covid-19 vaccines.
Neurimmune, the Swiss company that invented Aduhelm, will regain full rights to the intravenous medicine, Biogen said Wednesday.
The FDA's Adverse Event Reporting System needs modernization, experts say, with links to EHRs and better warning label strategies.
There is no evidence to support claims that IP waivers could expand access to shots, therapeutics, and diagnostics in the developing world.
The company had limited starter doses in the U.S. last year in the face of overwhelming demand and limited supply.
A judge grilled industry lawyers today over their contention that Medicare's drug price negotiation program is unconstitutional.
Cigna is officially exiting the Medicare business, agreeing to sell all of its MA plans to Health Care Service Corp. for $3.3 billion.
Hepatic encephalopathy in cirrhosis patients mirrors dementia but can be treated. A new analysis suggests liver disease is often missed.
Two types of breast cancer, one triple negative, the other with HER2 proteins, is one example of how the same name has different treatments.
